MANGALAM DRUGS Fact Sheet, MANGALAM DRUGS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MANGALAM DRUGS Fact Sheet    (MANGD)


Going LIVE Today at 5pm: The EV Gold Rush Special Event


Here is the latest financial fact sheet of MANGALAM DRUGS. For more details, see the MANGALAM DRUGS quarterly results and MANGALAM DRUGS share price and chart. For a sector overview, read our pharmaceuticals sector report.

MANGALAM DRUGS Price History

Price Rs 141.0
Mkt Cap Rs m 2,231
Vol '000 4.4
P/E X 9.3
P/CF X 6.0
EPS (TTM) Rs 15.2
% ch % -1.5
No. of shares m 15.83
% ch week % -0.4
% ch 1-mth % -2.8
% ch 12-mth % 4.4
52 week H/L Rs 196.5/91.0
(As on Oct 22, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

MANGALAM DRUGS Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
MANGALAM DRUGS EQUITY SHARE DATA
High Rs25622618260175 
Low Rs123126402032 
Sales per share (Unadj.) Rs185.3158.6124.0158.9221.1 
Earnings per share (Unadj.) Rs14.112.6-5.15.217.7 
Diluted earnings per shareRs14.112.6-5.15.217.7 
Cash flow per share (Unadj.) Rs17.216.7-0.610.423.5 
Dividends per share (Unadj.) Rs00.50000 
Adj. dividends per shareRs0.000.500.000.000.00 
Avg Dividend yield %00.3000 
Book value per share (Unadj.) Rs54.165.660.465.782.7 
Adj. book value per shareRs54.265.660.465.782.7 
Shares outstanding (eoy) m15.8315.8315.8315.8315.83 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x1.01.10.90.30.5 
Avg P/E ratio x13.514.0-21.97.75.9 
P/CF ratio (eoy) x11.010.5-186.63.94.4 
Price / Book Value ratio x3.52.71.80.61.3 
Dividend payout %04.0000 
Avg Mkt Cap Rs m3,0022,7811,7586351,639 
No. of employees `000NANANANANA 
Total wages/salary Rs m191230258260299 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
MANGALAM DRUGS INCOME DATA
Net Sales Rs m2,9332,5111,9632,5163,500 
Other income Rs m3831247 
Total revenues Rs m2,9362,5191,9672,5283,547 
Gross profit Rs m45946997237533 
Depreciation Rs m5066718292 
Interest Rs m1001188610493 
Profit before tax Rs m312293-5763395 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m899523-20115 
Profit after tax Rs m223199-8083280 
Gross profit margin %15.718.74.99.415.2 
Effective tax rate %28.632.2-40.0-32.029.2 
Net profit margin %7.67.9-4.13.38.0 
MANGALAM DRUGS BALANCE SHEET DATA
Current assets Rs m9581,2281,0501,1921,320 
Current liabilities Rs m7789989081,0951,076 
Net working cap to sales %6.19.27.23.97.0 
Current ratio x1.21.21.21.11.2 
Inventory Days Days335137 
Debtors Days Days466633580559 
Net fixed assets Rs m9371,0391,0631,1151,309 
Share capital Rs m158158158158158 
"Free" reserves Rs m6998797988811,151 
Net worth Rs m8571,0389571,0391,310 
Long term debt Rs m169111864269 
Total assets Rs m1,8952,2682,1142,3072,628 
Interest coverage x4.13.50.31.65.2 
Debt to equity ratio x0.20.10.100.1 
Sales to assets ratio x1.51.10.91.11.3 
Return on assets %17.114.00.38.114.2 
Return on equity %26.019.2-8.47.921.4 
Return on capital %40.235.82.815.435.4 
Exports to sales %00000 
Imports to sales %53.367.769.659.443.0 
Exports (fob) Rs m00000 
Imports (cif) Rs m1,5621,7001,3661,4961,506 
Fx inflow Rs m8505884239191,421 
Fx outflow Rs m1,5671,7061,3721,4991,507 
Net fx Rs m-717-1,118-949-580-85 
MANGALAM DRUGS CASH FLOW
From Operations Rs m 428 246 217 305 276 
From Investments Rs m -394 -160 -93 -69 -313 
From Financial Activity Rs m -32 -88 -114 -235 27 
Net Cashflow Rs m 1 -2 10 2 -10 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 50.5%
Institution 0.0%
Non-Institution 49.5%
Total 100.0%
Free Float 49.5%
Pledged promoter holdings 11.6%
 

Company Information

REGD OFF 3 Floor, 237 Rupam Building, P. D. Mello Road, Mumbai - 400001
E-MAIL contactus@mangalamdrugs.com WEB www.mangalamdrugs.com
TEL 022-22616200/ 6300/8787 FAX 022-2619090
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 1972 BSE CODE: 532637 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   NUTRAPLUS PR  MARKSANS PHARMA.  GLAND PHARMA  S.S.ORGANICS  LUPIN  

Compare MANGALAM DRUGS With:   NUTRAPLUS PR  MARKSANS PHARMA.  GLAND PHARMA  S.S.ORGANICS  LUPIN  




Today's Market

Sensex, Nifty Continue Downtrend to End Lower for 4th Day; Metal & IT Stocks Drag(Closing)

After opening the day on a positive note, Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks (Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution (Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You... (Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally (Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK MANGALAM DRUGS

  • Track your investment in MANGALAM DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON MANGALAM DRUGS

MANGALAM DRUGS 8-QTR ANALYSIS

COMPARE MANGALAM DRUGS WITH

MARKET STATS